R C O Melo, A A Martins, G H A Vieira, R V S Andrade, D N A Silva, J Chalmers, T M Silveira, F Q Pirih, V S Araújo, J S P Silva, M L D S Lopes, R F C Leitão, R F Araújo Júnior, I L G Silva, L J T Silva, E G Barbosa, A A Araújo
Considering the lack of consensus related to the impact of selective IL-6 receptor inhibition on bone remodeling and the scarcity of reports, especially on large bone defects, this study proposed to evaluate the biological impact of the selective inhibitor of interleukin-6 receptor (tocilizumab) in an experimental model of critical calvarial defect in rats. In this preclinical and in vivo study, 24 male Wistar rats were randomly divided into two groups (n=12/group): defect treated with collagen sponge (CG) and defect treated with collagen sponge associated with 2 mg/kg tocilizumab (TCZ)...
2024: Brazilian Journal of Medical and Biological Research